People: Flamel Technologies SA (FLML.W)

FLML.W on CBOE When Trading NASDAQ Global Select Market

4.77USD
13 May 2013
Price Change (% chg)

$0.11 (+2.36%)
Prev Close
$4.66
Open
$4.77
Day's High
$4.77
Day's Low
$4.77
Volume
100
Avg. Vol
6
52-wk High
$5.49
52-wk Low
$3.08

Search Stocks

Summary

Name Age Since Current Position

Stephen Willard

 52 2012 Chairman of the Board

Michael Anderson

 60 2012 Chief Executive Officer, Director

Sian Crouzet

 2008 Principal Financial Officer

Rafael Jorda

 2005 Chief Operating Officer, Executive Vice President

Steven Lisi

 2012 Senior Vice President - Business and Corporate Development

Jean Chatellier

 2010 Vice President - Alliance Management

Nigel McWilliam

 Vice President - Business Development

Martine Capelle

 2006 Human Resources Director

Yves Bourboulou

 2005 Industrial Director, Director - Manufacturing Facility

Catherine Castan

 Director - Micropump Platform (Oral Drugs) and Intellectual Property

You-Ping Chan

 Director - Chemistry Department And Analysis

Christian Kalita

 2005 Pharmacist and Director - Quality Assurance and Regulatory Affairs

Roger Kravtzoff

 2002 Preclinical and Early Clinical Development Director

Remi Meyrueix

 2008 Director - Physico-Chemistry, Director of Medusa Platform

David Weber

 Supply Chain Director

Elie Vannier

 63 2012 Director

Catherine Brechignac

 2011 Independent Director

Guillaume Cerutti

 2011 Independent Director

Lodewijk de Vink

 67 2006 Independent Director

Francis Fildes

 2008 Independent Director

Craig Stapleton

 67 2011 Independent Director

John Vogelstein

 2005 Independent Director
» Insider Trading

Biographies

Name Description

Stephen Willard

 Mr. Stephen H. Willard has been appointed as Chairman of the Board of Flamel Technologies S.A., effective June 22, 2012. He is Director since 2001. Prior to being asked to serve as CEO by the Board of Directors in June of 2005, Mr. Willard was the Company’s Chief Financial Officer and General Counsel. Prior to joining the Company in August 2000, Mr. Willard was Vice President of Biovail Corporation (now Valeant Pharmaceuticals International, Inc.; NYSE/TSX: VRX). He previously served as Associate Director of Resolutions of the Federal Deposit Insurance Corporation ("FDIC") of the USA. Mr. Willard worked also as an investment banker at Credit Suisse First Boston and as an attorney with Gibson, Dunn & Crutcher LLP and Shearman & Sterling LLP. He is a member of the Board of Directors of E-Trade Financial Corporation (NASDAQ: ETFC) since April 2005. Mr. Willard is a Juris Doctorate of Yale Law School (USA) and received a Bachelor of Arts degree from Williams College (USA).

Michael Anderson

 Mr. Michael S. Anderson serves as Chief Executive Officer, Director of Flamel Technologies S.A. He has been appointed as Director of the Company, effective June 22, 2012. He serves as Chief Executive Officer of the Company, since March 13, 2012. He has also served as Chief Executive Officer of Éclat Pharmaceuticals LLC since its formation in November 2010. Previously Mr. Anderson worked for KV Pharmaceuticals as President and CEO of its generic business, ETHEX Corporation and President and CEO of Ther-Rx Corporation, a in women’s healthcare. Mr. Anderson also has worked for Schein Pharmaceuticals and started his career at A.H Robins.

Sian Crouzet

 Mrs. Sian Crouzet is Principal Financial Officer of Flamel Technologies SA., since March 3, 2008. She previously worked as Financial Controller France for McCormick & Company Inc. Mrs. Crouzet also worked five years as an external auditor with Ernst and Young (France and UK). She is a UK Chartered Accountant and a graduate of Bradford University (UK).

Rafael Jorda

 Mr. Rafael Jorda is Chief Operating Officer, Executive Vice President of Flamel Technologies SA. He joined the Company in early 1991. Previously, Mr. Jorda had worked 14 years as a research and development scientist on controlled-released and biopolymers at Rhone-Poulenc. He specializes in chemical engineering and in the structure-property relationships of materials. Mr Jorda is a graduate of “Ecole Nationale Supérieure de Chimie de Lyon” (France).

Steven Lisi

 Mr. Steven Lisi has been appointed as Senior Vice President - Business and Corporate Development of Flamel Technologies SA., effective June 25, 2012. Mr. Lisi joins Flamel from Deerfield Capital Management, where he helped manage the firm's healthcare portfolio and worked on numerous strategic transactions in the healthcare space.

Jean Chatellier

 Dr. Jean Chatellier is Vice President - Alliance Management of Flamel Technologies SA. He served previously as Director of Business Development at Micromet AG (Nasdaq: MITI) and supported other business development activities for Crucell (Nasdaq: CRXL) and Viropro Inc. (PINK: VPRO). Mr Chatellier also was the founder and CEO of Imaxio SA, and was ex-CEO and liquidator of Aptanomics SA. He holds a binational Ph.D. in Protein Engineering from Strasbourg, France and Montréal, Canada and performed post-doctoral research with Sir Allan Fersht and Sir Greg Winter at the Center for Protein Engineering of the Medical Research Council in Cambridge UK.

Nigel McWilliam

 Mr. Nigel McWilliam is Vice President - Business Development of Flamel Technologies SA. He joined the Company in its Washington office in August 2005. Mr. McWilliam spent 20 years with Dow Corning Corporation’s Health Care Businesses in commercial positions in Europe and the U.S. He also has held various senior positions in the pharmaceutical industry, including President of Leiras Inc., the U.S. subsidiary of a Finnish pharmaceutical company (now part of Bayer-Schering, AG), CEO of Veos Ltd., and Senior V.P. Business Development at SkyePharma. Mr. McWilliam has a Bachelor degree in Science from the University of Dundee.

Martine Capelle

 Ms. Martine Capelle is Human Resources Director of Flamel Technologies SA., since 2006. She previously worked for the Danone group for 15 years in different Human Resource functions and roles and prior to that she worked as Human Relations manager for two automobile plants. She is a graduate of Lyon Human Sciences University.

Yves Bourboulou

 Mr. Yves Bourboulou is Industrial Director, Director - Manufacturing Facility of Flamel Technologies SA. He worked previously as Plant Manager at Pharmacia and Fresenius Kabi. Mr. Bourboulou previously held various senior positions, including Quality Assurance Director and Chief Pharmacist in the Pharmaceutical Industry. He has more than 20 years experience in pharmaceutical production, quality and development.

Catherine Castan

 Mrs. Catherine Castan is Director - Micropump Platform (Oral Drugs) and Intellectual Property of Flamel Technologies SA. She joined the Company in 1992 after having spent four years at Sanofi Recherche. Mrs. Castan is a graduate of “Ecole Nationale Supérieure de Chimie de Montpellier” and has a Ph.D. in polymer chemistry, applied in drug delivery.

You-Ping Chan

 Mr. You-Ping Chan is Director - Chemistry Department And Analysis of Flamel Technologies SA. He joined the Company in 1992 as a researcher in polymer science after post-doctoral research at the Massachusetts Institute of Technology (USA). He received his Ph. D in Chemistry from Strasbourg, France.

Christian Kalita

 Mr. Christian Kalita is Pharmacist and Director - Quality Assurance and Regulatory Affairs of Flamel Technologies SA., since 2005. He worked previously at Skye Pharma as Director of Quality for Europe. Mr. Kalita also worked at Merck Lipha and Merck generics for 10 years in different roles as Chief Pharmacist, Head of Quality Control Management and Head of Industrial Affairs.

Roger Kravtzoff

 Dr. Roger Kravtzoff is Preclinical and Early Clinical Development Director of Flamel Technologies SA. He joined the Company in June 2002. Previously, Mr. Kravtzoff worked as Project Director at Biovector Therapeutics and held senior scientific positions at Novacell and the “Centre Regional de Transfusion Sanguine”. Mr. Kravtzoff obtained a Ph.D. in Biochemistry from Tours, France.

Remi Meyrueix

 Dr. Remi Meyrueix is Director of Physico-Chemistry of Flamel Technologies SA. He joined the Company in early 1991 after having spent eight years at Rhone Poulenc. Mr. Meyrueix holds an engineer degree and a Ph.D. in physics from the Polytechnic Institute of Grenoble (France).

David Weber

 Mr. David Weber is Supply Chain Director of Flamel Technologies SA. He has more than ten years of experience in purchasing and operations management at various international companies including Garrett (Honeywell group) and Isringhausen. Before joining the company he was Vice President and Co-founder of Pertinence Data Intelligence.

Elie Vannier

 Mr. Elie Vannier serves as Director of Flamel Technologies S.A. He resigned as Non-Executive Independent Chairman of the Board of the Company, effective June 22, 2012. He is the former Group Managing Director of WALLY, former Chief Operating Officer of GrandVision SA, and a current Director of Ingénico, Famar, Conbipel and Pharmacie Principale.

Catherine Brechignac

 Dr. Catherine Brechignac is Independent Director of Flamel Technologies SA. She graduated and received her PhD in Physics from the Ecole Normale Supérieure. She is a member and the "Secrétaire Perpétuel" of the French National Academy of Sciences, a member of the French National Academy of Technologies, a member of the American Academy of Arts & Sciences, a member of the Royal Belgium Academy of Sciences, and also serves as the French Ambassador for science, technology and innovation. In addition, Dr Bréchignac is a former Chairperson of the National Center for Scientific Research (CNRS); she served as the first Chairperson of the "Haut Conseil des Biotechnologies" (2009-2011); and she was until recently (2008-2011) the Chairperson of the International Council for Science. Dr. Bréchignac has served as a board member of Renault SA, and was a Professor at the Georgia Institute of Technology, Member of the International Union of Pure and Applied Physics and Member of the European Physical Society. She has been awarded the French Légion d'Honneur and has received honorary doctorates from the Ecole Polytechnique Fédérale in Lausanne, the Georgia Tech Institute, and the Freie Universität Berlin. She was awarded, among numerous prizes, the prize of the Académie des Sciences in 1991 for her ground-breaking research.

Guillaume Cerutti

 Mr. Guillaume Cerutti is Independent Director of Flamel Technologies SA. Mr. Cerutti is the Chairman and CEO of Sothebys France. He graduated from the Ecole Nationale d'Administration (ENA) in 1991 and began his career as a civil servant at the Ministry of Finance and the Economy where he worked as a member of the Inspection Générale des Finances. He was the head of the "Direction Générale de la Concurrence et de la Répression des Fraudes" (the French administration charged with enforcing all anti-trust and fraud related issues). He was the Managing Director of the Centre Georges Pompidou between 1996 and 2001. Between 2002 and 2004 he served as chief of staff of France's Minister for Culture and Media, and played a decisive role in the preparation of the laws that reformed corporate sponsorship in France. He currently serves as a director of Ingenico SA, and chairman of the Institut de Financement du Cinéma et des Industries Culturelles (IFCIC), a financial company which offers guarantees and loans in the cultural sector in France.

Lodewijk de Vink

 Mr. Lodewijk J. R. de Vink is Independent Director of Flamel Technologies SA., since 2006. He is the former President of Schering Plough International, former Chairman and Chief Executive Officer of Warner Lambert, Inc., a Director of Roche, and a Member of the European Advisory Council of Rothschild.

Francis Fildes

 Dr. Francis J.T Fildes, Ph.D., is Independent Director of Flamel Technologies SA., since 2008. He is the former Senior Vice President: Head of Global Development for AstraZeneca, PLC, former Director of ProStrakan Pharmaceuticals PLC and a current Director of Fildes Partners Ltd and a Fellow of the Royal Society of Medicine and the Royal Society of Chemistry.

Craig Stapleton

 The Honorable, Ambassador, Craig R. Stapleton is Independent Director of Flamel Technologies SA. He served the United States as Ambassador to France from 2005 until 2009 after having served as the United States Ambassador to Prague. Ambassador Stapleton served as President of Marsh and McLennan Real Estate Advisors of New York from 1982 until 2001. He has served on the board of directors for several companies including Allegheny Properties, Metro PCS, TB Woods and Winston Partners. He was a part owner of the Texas Rangers baseball team from 1989-1998 and is currently a part owner of the St. Louis Cardinals. Ambassador Stapleton is currently serving as a Trustee of the George W. Bush Library and Foundation, the 9/11 Memorial Foundation, the de Tocqueville/United Way Foundation, CERGE (the Center for Economic Research and Graduate Education), and the Association François-Xavier Bagnoud. He has served on the Visiting Committee for Harvard College and the Committee on University Resources. Ambassador Stapleton is President of the Vaclav Havel Foundation in the United States. He currently serves as a Senior Advisor to Stone Point Capital and is the lead director of Abercrombie and Fitch. He received his B.A. (magna cum laude) from Harvard University and his M.B.A. from Harvard Business School.

John Vogelstein

 Mr. John L. Vogelstein is Independent Director of Flamel Technologies SA., since 2005. Mr. Vogelstein is former President of Warburg Pincus and a Senior Advisor of Warburg Pincus and Chairman of New Providence Asset Management; Chairman of the New York City Ballet, Chairman of Prep for Prep, Vice Chairman of the Overseers Board of The Leonard N. Stern School of Business at New York University, Chairman of Third Way, Director of the Jewish Museum, Chairman of Christie’s Advisory Board.

Insider Trading

» Full list on Insider Trading
Search Stocks